Adam Mumy
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Epigenetics and DNA Methylation, Bladder and Urothelial Cancer Treatments, RNA modifications and cancer, Glutathione Transferases and Polymorphisms
Most-Cited Works
- → A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus(2013)916 cited
- → Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk(2012)82 cited
- → The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease(2014)32 cited
- → Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer(2012)28 cited
- → Prostate stem cell antigen (PSCA) and risk of bladder cancer: linking genotypes to functional mechanisms(2011)14 cited
- → A novel functional variant in 8q24 is associated with regulation of prostate stem cell antigen (PSCA) gene expression and bladder cancer risk(2011)2 cited
- → A Mixed Type 1 and Type 2 Kinase Inhibitor That Overrides FLT3 F691 and D835 Resistance Mutations(2016)2 cited
- → Supplementary Materials, Figures 1 - 3, Tables 1 - 4, 6 - 8 from The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease(2023)
- → Supplementary Table 5 from The 19q12 Bladder Cancer GWAS Signal: Association with Cyclin E Function and Aggressive Disease(2023)